Name of opportunity: 👀
Dexcom, Inc
Up 5.92% in the past day ☝️
Dexcom has reported that its worldwide revenue came in at $1.11 billion for fourth quarter 2024. This surpassed Q4 2023 results by 8%. Its Q4 results also revealed that its global customer base increased by 25%, reaching over 2.8 million users. These positive Q4 results might be why share prices have seen an increase.
Dexcom is currently showcasing healthy EBITDA, revenue, and cash flow per share. Analysts are calling this stock a ‘buy’, and it’s nearly a ‘strong buy’.
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of Dexcom might increase from $89.07 to $133.48 in the next 12 months. If you invested $1000, you might profit $498.58.
Dexcom has experienced a tough year, but the $1.11 billion in revenue surpassed the expected $1.10 billion, which might have reassured investors. Dexcom also saw international revenue grow by 17% at $311 million. Organic growth also grew by 19%. These positive results all might contribute to why Dexcom has seen a rise in price recently, as investor confidence may be high currently.
Last November, Dexcom announced a partnership with Oura, to provide an advanced health management system. Through connecting Oura’s Oura rings, and Dexcom’s glucose biosensors, the two companies aim to help customers manage and monitor their health. This strategic partnership might be one of the key driving factors behind Dexcom’s Q4 results and increased stock price.
Glucose monitoring systems 🏥
Dexcom manufactures and distributes glucose monitor systems to help those with diabetes manage the condition. Dexcom is headquartered in San Diego, California, United States. The company also operates internationally.
Which neme?: 🔍
Download Nemo Money to check out Dexcom. New users can grab our registration bonus up to a maximum of $50 on first deposit. Terms and conditions apply.
